LINC01088 and glioblastoma: To explore whether LINC01088 affects HLTF protein levels by regulating its degradation, we assessed the turnover rate of HLTF in GBM cells expressing LINC01088‐SH or LINC01088‐OE using the protein synthesis inhibitor cycloheximide (CHX).